← Open Payments lookup

ANGELA DAVIS: Open Payments

NPI 1740523919 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,597 in 89 payments from 13 companies in 2025. Trend: 2023 $825 · 2024 $1,309 · 2025 $1,597

Food & beverage: $1,597
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$313
Otsuka America Pharmaceutical, Inc.8$246
ABBVIE INC.15$237
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$234
Vanda Pharmaceuticals Inc.13$196
Takeda Pharmaceuticals U.S.A., Inc.6$109
Alkermes, Inc.4$80
Lundbeck LLC3$51
E.R. Squibb & Sons, L.L.C.3$49
Integra LifeSciences Corporation1$34

Products named: INGREZZA, REXULTI, VRAYLAR, CAPLYTA, FANAPT, TRINTELLIX, ARISTADA, COBENFY.

Industry payments across NJ — which companies pay providers there.